A clinical trial to evaluate the effect of an Ayurvedic medicine, varyadi kashaya in patients with raised blood levels of uric acid.

Pharmacognostic, experimental and clinical study of hypouricemic activity of Varyadi kashaya for the treatment of Vatarakta w.s.r. to Gout.

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/03/050452

Enrollment

Registered

2023-03-07

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS HAVING CLASSICAL SYMPTOMS OF VATARAKTA(GOUT) WILL BE SELECTED FROM OPD AND IPD. TODA (PRICKING PAIN) BHEDA (TEARING PAIN) DAHA (BURNING SENSATION) SUPTI (NUMBNESS) SOPHA (SWELLING) RAGA (REDNESS)

Exclusion criteria

Exclusion criteria: PATIENTS BELLOW 20 AND ABOVE 65 YEARS OF AGE. PATIENTS WITH HEART DISEASE, MALIGNANCY, PREGNANT, SEVERE RENAL DISEASE, SEVERE HEPATIC DISEASE AND ANY OTHER CONDITION WHICH THE PRINCIPAL INVESTIGATOR THINKS MAY JEOPARDIZE THE STUDY.

Design outcomes

Primary

Measure	Time frame
MEAN PERCENTAGE DECREASE IN SERUM URIC ACID LEVEL FROM THE BASELINE TO THE END OF STUDY.Timepoint: DECREASE THE SERUM URIC ACID LEVEL AFTER 15 DAYS AND 30 DAYS OF TREATMENT.	—

Secondary

Measure	Time frame
RELIEF IN THE CLINICAL SYMPTOMS OF VATARAKTA (GOUT) TODA (PRICKING PAIN) BHEDA (TEARING PAIN) DAHA (BURNING SENSATION) SUPTI (NUMBNESS) SOPHA (SWELLING) RAGA (REDNESS)Timepoint: UPTO 30 DAYS	—

Countries

India

Contacts

Public ContactBARIN DAS

DEPARTMENT OF DRAVYAGUNA INSTITUTE OF POST GRADUATE AYURVEDIC EDUCATION AND RESEARCH AT S.V.S.P.

barindas21app@gmail.com8296020444

Outcome results